Viking Therapeutics shares owned by Duquesne Family Office
Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Duquesne Family Office
from 13F filings
Historical chart of Duquesne Family Office investment in Viking Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viking Therapeutics held by Duquesne Family Office consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viking Therapeutics by Duquesne Family Office
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $15M | 549k | 26.50 |